Research group Per Eriksson
The aim of the Ehrenborg team is to characterize physiological and molecular consequences of genetic variability in important proteins involved in the development of cardiovascular metabolic diseases and investigate the regulation of these proteins.
The long-term interest of the Eriksson team is to study the molecular mechanisms underlying aortic aneurysm.
Rachel Fisher investigates the development of cardiometabolic disease through studies of lipid metabolism in human liver and adipose tissue.
The aim of our research is to identify clinical and molecular profiles, so called endotypes, able to identify individuals at risk for atherosclerosis related cardiovascular diseases.
The Hagberg team aims to elucidate early cellular mechanisms in our white adipose tissue that contribute to the development of obesity-induced metabolic disorders, focusing on nutrient biochemistry.
The aim of our team is to identify and understand the key immunometabolic reactions controlling inflammation in the vascular wall and to develop new therapeutic targets to prevent and treat cardiovascular disease.
The major focus of the Paolino team is to explore the functions and mechanisms of ubiquitin-dependent pathways in metabolism, cancer and immunity.